You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nonmyeloablative conditioning.

Showing 1 - 25 of 1,422
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sickle Cell Disease Trial in Saint Louis (drug, radiation, procedure)

Terminated
  • Sickle Cell Disease
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 28, 2022

Hematologic Malignancies Trial in La Jolla (Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant)

Suspended
  • Hematologic Malignancies
  • Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant
  • La Jolla, California
    UCSD Medical Center
Jul 20, 2022

Malignant Tumor Trial in Los Angeles (biological, drug, other, radiation, procedure)

Active, not recruiting
  • Malignant Neoplasm
  • aldesleukin
  • +7 more
  • Los Angeles, California
    University of California at Los Angeles (UCLA )
Dec 1, 2022

Sickle Cell Disease, Stem Cell Transplant Complications, Red Blood Cell Disorder Trial in Calgary (Alemtuzumab, Total Body

Recruiting
  • Sickle Cell Disease
  • +3 more
  • Calgary, Alberta, Canada
    Alberta Children's Hospital
May 25, 2021

Myelodysplastic Syndrome (MDS) With Refractory Anemia (RA), Severe Aplastic Anemia (SAA) Trial run by the NHLBI (Umbilical Cord

Completed
Has Results
  • Myelodysplastic Syndrome (MDS) With Refractory Anemia (RA)
  • Severe Aplastic Anemia (SAA)
  • Umbilical Cord Blood
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 16, 2021

Metastatic Melanoma Trial in Los Angeles (F5 TCR transgenic cells and MART-1 peptide pulsed dendritic cells, non-myeloablative

Completed
Has Results
  • Metastatic Melanoma
  • F5 TCR transgenic cells and MART-1 peptide pulsed dendritic cells
  • non-myeloablative conditioning chemotherapy
  • Los Angeles, California
    University of California Los Angeles, David Geffen School of Med
Dec 3, 2021

Hematological Malignancies Trial in Belgium, Netherlands (Conditioning regimen: TBI + Fludarabine, Conditioning regimen:TLI (8

Completed
Has Results
  • Hematological Malignancies
  • Conditioning regimen: TBI + Fludarabine
  • Conditioning regimen:TLI (8 Gy) + ATG
  • Leuven, Flamish Brabant, Belgium
  • +10 more
Nov 16, 2021

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic

Recruiting
  • Acute Lymphoblastic Leukemia
  • +16 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 1, 2022

Multiple Myeloma, Refractory Multiple Myeloma Trial (procedure, drug, radiation)

Withdrawn
  • Multiple Myeloma
  • Refractory Multiple Myeloma
  • nonmyeloablative allogeneic hematopoietic stem cell transplantation
  • +7 more
  • (no location specified)
Jan 4, 2023

Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, Leukemia, Myelocytic, Chronic Trial in Belgium (Mesenchymal stem

Terminated
  • Leukemia, Myeloid, Acute
  • +8 more
  • Mesenchymal stem cells
  • Isotonic solution
  • Edeghem, Antwerpen, Belgium
  • +9 more
Aug 31, 2021

Leukemia, Lymphoma Trial in Houston (Rituximab, 111In Ibritumomab, Planar Scintigraphy Imaging)

Completed
Has Results
  • Leukemia
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 23, 2020

Lupus Erythematosus, Graft-versus-host Disease Trial in Baltimore (drug, radiation, biological)

Terminated
Has Results
  • Lupus Erythematosus
  • Graft-versus-host Disease
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sep 19, 2019

Mycosis Fungoides, Sezary Syndrome Trial run by the NHLBI (A matched peripheral donor stem cells, cyclosporine, fludarabine)

Completed
Has Results
  • Mycosis Fungoides
  • Sezary Syndrome
  • A matched peripheral donor stem cells
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 2, 2020

Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (haploidentical stem cell transplant,

Recruiting
  • Sickle Cell Disease
  • haploidentical stem cell transplant
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 18, 2022

Immunodeficiency Syndrome, Severe Aplastic Anemia, Genetic Disorder Trial in Nashville, Seattle (procedure, drug, other,

Terminated
Has Results
  • Immunodeficiency Syndrome
  • +2 more
  • Allogeneic Bone Marrow Transplantation
  • +8 more
  • Nashville, Tennessee
  • +2 more
Jan 6, 2021

Sickle Cell Disease Trial in Canada, United States (Alemtuzumab intravenously, low dose total body irradiation, Sirolimus)

Recruiting
  • Sickle Cell Disease
  • Alemtuzumab intravenously, low dose total body irradiation, Sirolimus
  • Washington, District of Columbia
  • +5 more
Mar 2, 2022

Congenital Hemolytic Anemia, Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Peripheral

Recruiting
  • Congenital Hemolytic Anemia
  • Sickle Cell Disease
  • Peripheral blood hematopoietic progenitor cell (PBPC) transplant
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood

Recruiting
  • Hematopoietic Malignancy
  • +2 more
  • Umbilical Cord Blood Transplantation
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow university
Nov 6, 2023

Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute

Completed
Has Results
  • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +5 more
  • Therapeutic Allogeneic Lymphocytes
  • Seattle, Washington
  • +3 more
Jan 15, 2020

Severe Combined Immune Deficiency (SCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

Enrolling by invitation
  • Severe Combined Immune Deficiency (SCID)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Chronic Granulomatous Disease Transplant Trial run by the NIAID (drug, radiation, biological)

Active, not recruiting
  • Chronic Granulomatous Disease Transplant
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 21, 2023

Multiple Myeloma, High-Risk Cancer Trial in Montreal (Bortezomib following nonmyeloablative allogeneic transplant)

Active, not recruiting
  • Multiple Myeloma
  • High-Risk Cancer
  • Bortezomib following nonmyeloablative allogeneic transplant
  • Montreal, Quebec, Canada
    Hôpital Maisonneuve-Rosemont
Aug 22, 2022

Sickle Cell Disease, Thalassemia, Stem Cell Transplantation Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

Recruiting
  • Sickle Cell Disease
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies Trial in Duarte (Cyclophosphamide, Pentostatin, Rabbit

Recruiting
  • Sickle Cell Disease
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jul 6, 2022

Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in

Completed
Has Results
  • Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
  • +13 more
  • Salt Lake City, Utah
  • +2 more
Jan 15, 2020